|
1
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sundaram S and Niklason LE: Smooth muscle
and other cell sources for human blood vessel engineering. Cells
Tissues Organs. 195:15–25. 2012.PubMed/NCBI
|
|
3
|
Xu ZC, Zhang WJ, Li H, Cui L, Cen L, Zhou
GD, Liu W and Cao Y: Engineering of an elastic large muscular
vessel wall with pulsatile stimulation in bioreactor. Biomaterials.
29:1464–1472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poh M, Boyer M, Solan A, Dahl SL, Pedrotty
D, Banik SS, McKee JA, Klinger RY, Counter CM and Niklason LE:
Blood vessels engineered from human cells. Lancet. 365:2122–2124.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McKee JA, Banik SS, Boyer MJ, Hamad NM,
Lawson JH, Niklason LE and Counter CM: Human arteries engineered in
vitro. EMBO Rep. 4:633–638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bajpai VK and Andreadis ST: Stem cell
sources for vascular tissue engineering and regeneration. Tissue
Eng Part B Rev. 18:405–425. 2012.PubMed/NCBI
|
|
7
|
Matsumura G, Miyagawa-Tomita S, Shin’oka
T, Ikada Y and Kurosawa H: First evidence that bone marrow cells
contribute to the construction of tissue-engineered vascular
autografts in vivo. Circulation. 108:1729–1734. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shin’oka T, Matsumura G, Hibino N, Naito
Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M and Kurosawa H:
Midterm clinical result of tissue-engineered vascular autografts
seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg.
129:1330–1338. 2005.
|
|
9
|
Gong ZD and Niklason LE: Small-diameter
human vessel wall engineered from bone marrow-derived mesenchymal
stem cells (hMSCs). FASEB J. 22:1635–1648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heydarkhan-Hagvall S, Schenke-Layland K,
Yang JQ, Heydarkhan S, Xu Y, Zuk PA, MacLellan WR and Beygui RE:
Human adipose stem cells: a potential cell source for
cardiovascular tissue engineering. Cells Tissues Organs.
187:263–274. 2008.PubMed/NCBI
|
|
11
|
Wang C, Cen L, Yin S, Liu Q, Liu W, Cao Y
and Cui L: A small diameter elastic blood vessel wall prepared
under pulsatile conditions from polyglycolic acid mesh and smooth
muscle cells differentiated from adipose-derived stem cells.
Biomaterials. 31:621–630. 2010. View Article : Google Scholar
|
|
12
|
Harris LJ, Abdollahi H, Zhang P, McIlhenny
S, Tulenko TN and DiMuzio PJ: Differentiation of adult stem cells
into smooth muscle for vascular tissue engineering. J Surg Res.
168:306–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsu YC, Pasolli HA and Fuchs E: Dynamics
between stem cells, niche, and progeny in the hair follicle. Cell.
144:92–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mistriotis P and Andreadis ST: Hair
Follicle: a novel source of multipotent stem cells for tissue
engineering and regenerative medicine. Tissue Eng Part B Rev.
19:265–278. 2013.PubMed/NCBI
|
|
15
|
Jahoda CA, Whitehouse J, Reynolds AJ and
Hole N: Hair follicle dermal cells differentiate into adipogenic
and osteogenic lineages. Exp Dermatol. 12:849–859. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu H, Fang D, Kumar SM, Li L, Nguyen TK,
Acs G, Herlyn M and Xu X: Isolation of a novel population of
multipotent adult stem cells from human hair follicles. Am J
Pathol. 168:1879–1888. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Drewa T, Joachimiak R, Kaznica A, Sarafian
V and Pokrywczynska M: Hair stem cells for bladder regeneration in
rats: preliminary results. Transplant Proc. 41:4345–4351. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin H, Liu F, Zhang C, Zhang Z, Kong Z,
Zhang X and Hoffman RM: Characterization of nerve conduits seeded
with neurons and Schwann cells derived from hair follicle neural
crest stem cells. Tissue Eng Part A. 17:1691–1698. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dickson MC, Martin JS, Cousins FM,
Kulkarni AB, Karlsson S and Akhurst RJ: Defective haematopoiesis
and vasculogenesis in transforming growth factor-beta 1 knock out
mice. Development. 121:1845–1854. 1995.PubMed/NCBI
|
|
20
|
Shah NM, Groves AK and Anderson DJ:
Alternative neural crest cell fates are instructively promoted by
TGFbeta superfamily members. Cell. 85:331–343. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grainger DJ, Metcalfe JC, Grace AA and
Mosedale DE: Transforming growth factor-beta dynamically regulates
vascular smooth muscle differentiation in vivo. J Cell Sci.
111:2977–2988. 1998.PubMed/NCBI
|
|
22
|
Hirschi KK, Rohovsky SA and D’Amore PA:
PDGF, TGFbeta, and heterotypic cell-cell interactions mediate
endothelial cell-induced recruitment of 10T1/2 cells and their
differentiation to a smooth muscle fate. J Cell Biol. 141:805–814.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S and Lechleider RJ: Transforming
growth factor-beta-induced differentiation of smooth muscle from a
neural crest stem cell line. Circ Res. 94:1195–1202. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hirschi KK, Burt JM, Hirschi KD and Dai C:
Gap junction communication mediates transforming growth factor-beta
activation and endothelial-induced mural cell differentiation. Circ
Res. 93:429–437. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ross JJ, Hong Z, Willenbring B, Zeng L,
Isenberg B, Lee EH, Reyes M, Keirstead SA, Weir EK, Tranquillo RT
and Verfaillie CM: Cytokine-induced differentiation of multipotent
adult progenitor cells into functional smooth muscle cells. J Clin
Invest. 116:3139–3149. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lindahl P, Johansson BR, Levéen P and
Betsholtz C: Pericyte loss and microaneurysm formation in
PDGF-B-deficient mice. Science. 277:242–245. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hellström M, Kalén M, Lindahl P, Abramsson
A and Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of
vascular smooth muscle cells and pericytes during embryonic blood
vessel formation in the mouse. Development. 126:3047–3055.
1999.PubMed/NCBI
|
|
28
|
Kim YM, Jeon ES, Kim MR, Jho SK, Ryu SW
and Kim JH: Angiotensin II-induced differentiation of adipose
tissue-derived mesenchymal stem cells to smooth muscle-like cells.
Int J Biochem Cell Biol. 40:2482–2491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Long JL and Tranquillo RT: Elastic fiber
production in cardiovascular tissue-equivalents. Matrix Biol.
22:339–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong Z and Niklason LE: Blood vessels
engineered from human cells. Trends Cardiovasc Med. 16:153–156.
2006. View Article : Google Scholar
|
|
31
|
Isenberg BC, Williams C and Tranquillo RT:
Small-diameter artificial arteries engineered in vitro. Circ Res.
98:25–35. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho SW, Lim SH, Kim IK, Hong YS, Kim SS,
Yoo KJ, Park HY, Jang Y, Chang BC, Choi CY, et al: Small-diameter
blood vessels engineered with bone marrow-derived cells. Ann Surg.
241:506–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rodriguez LV, Alfonso Z, Zhang R, Leung J,
Wu B and Ignarro LJ: Clonogenic multipotent stem cells in human
adipose tissue differentiate into functional smooth muscle cells.
Proc Natl Acad Sci USA. 103:12167–12172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beltrami AP, Cesselli D, Bergamin N,
Marcon P, Rigo S, Puppato E, D’Aurizio F, Verardo R, Piazza S,
Pignatelli A, et al: Multipotent cells can be generated in vitro
from several adult human organs (heart, liver, and bone marrow).
Blood. 110:3438–3446. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miano JM: Mammalian smooth muscle
differentiation: origins, markers and transcriptional control.
Results Probl Cell Differ. 38:39–59. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grainger DJ: Transforming growth factor
beta and atherosclerosis: so far, so good for the protective
cytokine hypothesis. Arterioscler Thromb Vasc Biol. 24:399–404.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Björkerud S: Effects of transforming
growth factor-beta 1 on human arterial smooth muscle cells in
vitro. Arterioscler Thromb. 11:892–902. 1991.PubMed/NCBI
|
|
38
|
Deaton RA, Su C, Valencia TG and Grant SR:
Transforming growth factor-beta1-induced expression of smooth
muscle marker genes involves activation of PKN and p38 MAPK. J Biol
Chem. 280:31172–31181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hautmann MB, Madsen CS and Owens GK: A
transforming growth factor beta (TGFbeta) control element drives
TGFbeta-induced stimulation of smooth muscle alpha-actin gene
expression in concert with two CArG elements. J Biol Chem.
272:10948–10956. 1997. View Article : Google Scholar
|
|
40
|
Kawai-Kowase K, Sato H, Oyama Y, Kanai H,
Sato M, Doi H and Kurabayashi M: Basic fibroblast growth factor
antagonizes transforming growth factor-beta1-induced smooth muscle
gene expression through extracellular signal-regulated kinase 1/2
signaling pathway activation. Arterioscler Thromb Vasc Biol.
24:1384–1390. 2004. View Article : Google Scholar
|
|
41
|
Papetti M, Shujath J, Riley KN and Herman
IM: FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte
alpha-smooth muscle actin expression: a role for myf-5 and
Smad-mediated signaling pathways. Invest Ophthalmol Vis Sci.
44:4994–5005. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kucich U, Rosenbloom JC, Abrams WR, Bashir
MM and Rosenbloom J: Stabilization of elastin mRNA by TGF-beta:
initial characterization of signaling pathway. Am J Respir Cell Mol
Biol. 17:10–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kucich U, Rosenbloom JC, Abrams WR and
Rosenbloom J: Transforming growth factor-beta stabilizes elastin
mRNA by a pathway requiring active Smads, protein kinase C-delta,
and p38. Am J Respir Cell Mol Biol. 26:183–188. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hong HH, Uzel MI, Duan C, Sheff MC and
Trackman PC: Regulation of lysyl oxidase, collagen, and connective
tissue growth factor by TGF-beta1 and detection in human gingiva.
Lab Invest. 79:1655–1667. 1999.PubMed/NCBI
|
|
45
|
Ross JJ and Tranquillo RT: ECM gene
expression correlates with in vitro tissue growth and development
in fibrin gel remodeled by neonatal smooth muscle cells. Matrix
Biol. 22:477–490. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yao L, Swartz DD, Gugino SF, Russell JA
and Andreadis ST: Fibrin-based tissue-engineered blood vessels:
differential effects of biomaterial and culture parameters on
mechanical strength and vascular reactivity. Tissue Eng.
11:991–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sinha S, Hoofnagle MH, Kingston PA,
McCanna ME and Owens GK: Transforming growth factor-beta1 signaling
contributes to development of smooth muscle cells from embryonic
stem cells. Am J Physiol Cell Physiol. 287:C1560–C1568. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kinner B, Zaleskas JM and Spector M:
Regulation of smooth muscle actin expression and contraction in
adult human mesenchymal stem cells. Exp Cell Res. 278:72–83. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang D, Park JS, Chu JS, Krakowski A, Luo
K, Chen DJ and Li S: Proteomic profiling of bone marrow mesenchymal
stem cells upon transforming growth factor beta1 stimulation. J
Biol Chem. 279:43725–43734. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Collins T, Pober JS, Gimbrone MA Jr,
Hammacher A, Betsholtz C, Westermark B and Heldin CH: Cultured
human endothelial cells express platelet-derived growth factor A
chain. Am J Pathol. 126:7–12. 1987.PubMed/NCBI
|
|
51
|
Westermark B, Siegbahn A, Heldin CH and
Claesson-Welsh L: B-type receptor for platelet-derived growth
factor mediates a chemotactic response by means of ligand-induced
activation of the receptor protein-tyrosine kinase. Proc Natl Acad
Sci USA. 87:128–132. 1990. View Article : Google Scholar
|
|
52
|
Holmgren L, Glaser A, Pfeifer-Ohlsson S
and Ohlsson R: Angiogenesis during human extraembryonic development
involves the spatiotemporal control of PDGF ligand and receptor
gene expression. Development. 113:749–754. 1991.
|
|
53
|
Hyytiäinen M, Penttinen C and Keski-Oja J:
Latent TGF-beta binding proteins: extracellular matrix association
and roles in TGF-beta activation. Crit Rev Clin Lab Sci.
41:233–264. 2004.PubMed/NCBI
|
|
54
|
Derynck R and Akhurst RJ: Differentiation
plasticity regulated by TGF-beta family proteins in development and
disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liang MS and Andreadis ST: Engineering
fibrin-binding TGF-β1 for sustained signaling and contractile
function of MSC based vascular constructs. Biomaterials.
32:8684–8693. 2011.PubMed/NCBI
|
|
56
|
Gallagher JT: Heparan sulfate: growth
control with a restricted menu. J Clin Invest. 108:357–361. 2001.
View Article : Google Scholar : PubMed/NCBI
|
